ALLO vs PYPL · rev $22.0K vs P/E 7.9, rev $33.17B
Allogene Therapeutics Inc (ALLO) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
ALLO currently screens at market cap $258.1M. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the ALLO and PYPL stock pages for the full models.
Not investment advice.